NEW YORK, Oct. 15, 2022 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
LogicBio Therapeutics, Inc. LOGC‘s sale to AstraZeneca Rare Disease for $2.07 per share. If you are an LogicBio shareholder, click here to learn more about your rights and options.
Imara Inc. IMRA‘s merger with Enliven Therapeutics, Inc. If you are an Imara shareholder, click here to learn more about your rights and options.
Silverback Therapeutics, Inc. SBTX‘s merger with ARS Pharmaceuticals, Inc. Under the terms of the merger agreement, assuming that Silverback’s net cash at closing is $240 million, Silverback equity holders are expected to own approximately 37% of the combined company. If you are a Silverback shareholder, click here to learn more about your rights and options.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.